Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 669
Selected: 0
NCT IDTitle
NCT00706654Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT03303105Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
NCT04186403Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
NCT03620981Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT01628926A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT06036108Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT03292848Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
NCT00479336A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT01000467Pharmacokinetics Study for Probucol
NCT02013531Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
NCT01252056A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
NCT02331680A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT00797966Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT01396421Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
NCT00162942Study for the Treatment of Crohn's Disease With Adacolumn
NCT03423680A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
NCT01972711Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
NCT01336972Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01981811Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT03709017Iclusig PMS in CML or Ph+ALL Patients
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT03376763MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
NCT00233363Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00934232Busulfan in Multiple Myeloma
NCT02755753A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
NCT03772041Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT00237939A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
NCT01890694Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01711333A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease
NCT00448357Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
NCT02547428Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
NCT01838681Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT00666965A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
NCT02473393A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
NCT00201994"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00272467Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
NCT01424670Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis
NCT01084551Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
NCT04038957A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT00606229A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT05687071A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT00362271Aripiprazole and Effexor XR Drug Interaction Study
NCT01683058Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT01862640A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation